Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01999556 · ClinicalTrials.gov registry record
LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 6
- Enrollment target
NCT01999556 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 6 participants.
The verdict
NCT01999556 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain high quality specimens for molecular studies for the identification and characterization of genetic mutations involved in the pathogenesis of familial myeloid malignancies. Specimens obtained will be de-identified, linked to basic clinical data, and sent to Washington University (Division of Oncology, St. Louis, MO) for molecular analyses. Some specimens sent to Washington University may also be used for quality control analyses.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-11 |
| Est. Completion | 2016-12-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01999556
The ClinicalTrials.gov registry entry for NCT01999556 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01999556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01999556 about?
NCT01999556 is a clinical study titled "LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia". The purpose of this study is to obtain high quality specimens for molecular studies for the identification and characterization of genetic mutations involved in the pathogenesis of familial myeloid malignancies. Specimens obtained will be de-identified, linked to basic clinical data, and sent to Was...
What is the current status of trial NCT01999556?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2013-11. Estimated completion is 2016-12-22.
Who is sponsoring clinical trial NCT01999556?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.